Alternatively, activation of TSHR-mediated proliferative cues in malignant thyrocytes can be minimized therapeutically by inducing pharmacologic hyperthyroidism, leading to suppression of endogenous TSH. This evidence concerns the gene TSHR and hyperthyroidism.